These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29955452)

  • 1. Second-generation antipsychotic use in borderline personality disorder: What are we targeting?
    Wasylyshen A; Williams AM
    Ment Health Clin; 2016 Mar; 6(2):82-88. PubMed ID: 29955452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-Label Use of Second-Generation Antipsychotics in Borderline Personality Disorder: A Survey of Italian Psychiatrists.
    Aguglia A; Serafini G; Nebbia J; Salvi V; Martinotti G; Corbo M; Signorelli MS; Mineo L; Mencacci C; Di Sciascio G; Biggio G; Aguglia E; Amore M
    J Pers Disord; 2021 Jun; 35(3):321-335. PubMed ID: 31609189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interventions for borderline personality disorder.
    Stoffers J; Völlm BA; Rücker G; Timmer A; Huband N; Lieb K
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005653. PubMed ID: 20556762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Clinical Psychopharmacology in Borderline Personality Disorder.
    Del Casale A; Bonanni L; Bargagna P; Novelli F; Fiaschè F; Paolini M; Forcina F; Anibaldi G; Cortese FN; Iannuccelli A; Adriani B; Brugnoli R; Girardi P; Paris J; Pompili M
    Curr Neuropharmacol; 2021; 19(10):1760-1779. PubMed ID: 34151763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic medication use in hospitalized patients with borderline personality disorder.
    Moeller KE; Din A; Wolfe M; Holmes G
    Ment Health Clin; 2016 Mar; 6(2):68-74. PubMed ID: 29955450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-Year Trends in the Psychopharmacological Treatment of Outpatients with Borderline Personality Disorder: A Cross-Sectional Naturalistic Study in Spain.
    Pascual JC; Martín-Blanco A; Soler J
    CNS Drugs; 2021 Sep; 35(9):1023-1032. PubMed ID: 34370282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis.
    Gartlehner G; Crotty K; Kennedy S; Edlund MJ; Ali R; Siddiqui M; Fortman R; Wines R; Persad E; Viswanathan M
    CNS Drugs; 2021 Oct; 35(10):1053-1067. PubMed ID: 34495494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overdose and off-label psychotropic prescribing in patients with borderline personality disorder: A retrospective series.
    Ning AY; Theodoros T; Harris K; Isoardi KZ
    Australas Psychiatry; 2023 Apr; 31(2):195-200. PubMed ID: 36772817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders.
    Bridler R; Häberle A; Müller ST; Cattapan K; Grohmann R; Toto S; Kasper S; Greil W
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):763-72. PubMed ID: 25907249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
    Maher AR; Theodore G
    J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of borderline personality disorder: replacing confusion with prudent pragmatism.
    Starcevic V; Janca A
    Curr Opin Psychiatry; 2018 Jan; 31(1):69-73. PubMed ID: 29028643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
    Mercer D; Douglass AB; Links PS
    J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociative states in borderline personality disorder and their relationships to psychotropic medication.
    Pec O; Bob P; Simek J; Raboch J
    Neuropsychiatr Dis Treat; 2018; 14():3253-3257. PubMed ID: 30538483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effectiveness of antipsychotics in borderline personality disorder: meta-analyses of placebo-controlled, randomized clinical trials on symptomatic outcome domains.
    Ingenhoven TJ; Duivenvoorden HJ
    J Clin Psychopharmacol; 2011 Aug; 31(4):489-96. PubMed ID: 21694626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label use of atypical antipsychotics in personality disorders.
    Rosenbluth M; Sinyor M
    Expert Opin Pharmacother; 2012 Aug; 13(11):1575-85. PubMed ID: 21933032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging medications for borderline personality disorder: is pharmacotherapy alone enough?
    Bozzatello P; Rocca P; De Rosa ML; Bellino S
    Expert Opin Pharmacother; 2020 Jan; 21(1):47-61. PubMed ID: 31693423
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacotherapy effectiveness for some symptoms of borderline personality disorder].
    Benjaminsen S
    Ugeskr Laeger; 2014 Sep; 176(36):. PubMed ID: 25293847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelines.
    Riffer F; Farkas M; Streibl L; Kaiser E; Sprung M
    Int J Psychiatry Clin Pract; 2019 Sep; 23(3):178-188. PubMed ID: 31140337
    [No Abstract]   [Full Text] [Related]  

  • 19. Lamotrigine for people with borderline personality disorder: a RCT.
    Crawford MJ; Sanatinia R; Barrett B; Cunningham G; Dale O; Ganguli P; Lawrence-Smith G; Leeson VC; Lemonsky F; Lykomitrou-Matthews G; Montgomery A; Morriss R; Munjiza J; Paton C; Skorodzien I; Singh V; Tan W; Tyrer P; Reilly JG
    Health Technol Assess; 2018 Apr; 22(17):1-68. PubMed ID: 29651981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Association Between Illicit Drug Use, Borderline Personality Disorder and Depression in a Help-Seeking Sample of Adolescents].
    Ghinea D; Parzer P; Resch F; Kaess M; Edinger A
    Prax Kinderpsychol Kinderpsychiatr; 2020 Mar; 69(2):126-140. PubMed ID: 32114950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.